1
|
Noël F, Mauroy B. Propagation of an idealized infection in an airway tree, consequences of the inflammation on the oxygen transfer to blood. J Theor Biol 2023; 561:111405. [PMID: 36639022 DOI: 10.1016/j.jtbi.2023.111405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2022] [Revised: 11/02/2022] [Accepted: 12/31/2022] [Indexed: 01/12/2023]
Abstract
A mathematical model of infection, inflammation and immune response in an idealized bronchial tree is developed. This work is based on a model from the literature that is extended to account for the propagation dynamics of an infection between the airways. The inflammation affects the size of the airways, the air flows distribution in the airway tree, and, consequently, the oxygen transfers to blood. We test different infections outcomes and propagation speed. In the hypotheses of our model, the inflammation can reduce notably and sometimes drastically the oxygen flow to blood. Our model predicts how the air flows and oxygen exchanges reorganize in the tree during an infection. Our results highlight the links between the localization of the infection and the amplitude of the loss of oxygen flow to blood. We show that a compensation phenomena due to the reorganization of the flow exists, but that it remains marginal unless the power produced the ventilation muscles is increased. Our model forms a first step towards a better understanding of the dynamics of bronchial infections.
Collapse
Affiliation(s)
- Frédérique Noël
- Université Côte d'Azur, CNRS, LJAD, Vader center, Nice, France; INRIA Paris, France.
| | - Benjamin Mauroy
- Université Côte d'Azur, CNRS, LJAD, Vader center, Nice, France.
| |
Collapse
|
2
|
di Cagno MP, Clarelli F, Våbenø J, Lesley C, Rahman SD, Cauzzo J, Franceschinis E, Realdon N, Stein PC. Experimental Determination of Drug Diffusion Coefficients in Unstirred Aqueous Environments by Temporally Resolved Concentration Measurements. Mol Pharm 2018; 15:1488-1494. [DOI: 10.1021/acs.molpharmaceut.7b01053] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Massimiliano Pio di Cagno
- Drug Transport and Delivery Research Group, Department of Pharmacy, University of Tromsø, The Arctic University of Norway, Tromsø 9037, Norway
| | - Fabrizio Clarelli
- Computational Pharmacology Group, Department of Pharmacy, University of Tromsø, The Arctic University of Norway, Tromsø 9037, Norway
| | - Jon Våbenø
- Helgeland Hospital Trust, 8800 Sandnessjøen, Norway
| | - Christina Lesley
- Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense, Denmark
| | - Sokar Darsim Rahman
- Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense, Denmark
| | - Jennifer Cauzzo
- Drug Transport and Delivery Research Group, Department of Pharmacy, University of Tromsø, The Arctic University of Norway, Tromsø 9037, Norway
- Department of Pharmaceutical Sciences, University of Padova, 35122 Padova, Italy
| | - Erica Franceschinis
- Department of Pharmaceutical Sciences, University of Padova, 35122 Padova, Italy
| | - Nicola Realdon
- Department of Pharmaceutical Sciences, University of Padova, 35122 Padova, Italy
| | - Paul C. Stein
- Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense, Denmark
| |
Collapse
|
3
|
Houben RMGJ, Dowdy DW, Vassall A, Cohen T, Nicol MP, Granich RM, Shea JE, Eckhoff P, Dye C, Kimerling ME, White RG. How can mathematical models advance tuberculosis control in high HIV prevalence settings? Int J Tuberc Lung Dis 2015; 18:509-14. [PMID: 24903784 PMCID: PMC4436821 DOI: 10.5588/ijtld.13.0773] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Existing approaches to tuberculosis (TB) control have been no more than partially successful in areas with high human immunodeficiency virus (HIV) prevalence. In the context of increasingly constrained resources, mathematical modelling can augment understanding and support policy for implementing those strategies that are most likely to bring public health and economic benefits. In this paper, we present an overview of past and recent contributions of TB modelling in this key area, and suggest a way forward through a modelling research agenda that supports a more effective response to the TB-HIV epidemic, based on expert discussions at a meeting convened by the TB Modelling and Analysis Consortium. The research agenda identified high-priority areas for future modelling efforts, including 1) the difficult diagnosis and high mortality of TB-HIV; 2) the high risk of disease progression; 3) TB health systems in high HIV prevalence settings; 4) uncertainty in the natural progression of TB-HIV; and 5) combined interventions for TB-HIV. Efficient and rapid progress towards completion of this modelling agenda will require co-ordination between the modelling community and key stakeholders, including advocates, health policy makers, donors and national or regional finance officials. A continuing dialogue will ensure that new results are effectively communicated and new policy-relevant questions are addressed swiftly.
Collapse
Affiliation(s)
- R M G J Houben
- TB Modelling Group, TB Centre, and Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine (LSHTM), London, UK
| | - D W Dowdy
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| | - A Vassall
- Department of Global Health and Development, LSHTM, London, UK
| | - T Cohen
- Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
| | - M P Nicol
- Division of Medical Microbiology and Institute of Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory Service, South Africa
| | - R M Granich
- Joint United Nations Programme on HIV/AIDS, World Health Organization (WHO), Geneva, Switzerland
| | - J E Shea
- Oxford-Emergent Tuberculosis Consortium, Wokingham, UK
| | - P Eckhoff
- Intellectual Ventures Laboratory, Bellevue, Washington, USA
| | - C Dye
- HIV, TB Malaria and Neglected Tropical Diseases Cluster, WHO, Geneva, Switzerland
| | - M E Kimerling
- Bill and Melinda Gates Foundation, Seattle, Washington, USA
| | - R G White
- TB Modelling Group, TB Centre, and Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine (LSHTM), London, UK
| | | |
Collapse
|